Physician profile
Pablo Castaneda
NPI 1497296347
$10,305.75
in general payments reported to CMS, 2019-2025
11 companies · $204 in 2025
The $204 reported for 2025 was less than what a typical Pediatric Orthopaedic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2020: $1,625 · 2021: $2,400 · 2022: $71.57 · 2023: $2,030 · 2024: $3,779 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,044 · Consulting Fee: $700 · Food and Beverage: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,043.56 |
| Consulting Fee | $700.00 |
| Food and Beverage | $269.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthopediatrics Corp. | $7,842.71 | 2020-2025 | |
| Endo Pharmaceuticals INC. | $700.00 | 2023 | |
| Orthofix Medical, INC. | $609.82 | 2023 | 7d Surgical System |
| Arthrex, INC. | $448.48 | 2023 | |
| Suvon Surgical LLC | $272.03 | 2023 | |
| Zimmer Biomet Holdings, INC. | $118.16 | 2019 | |
| Nuvasive Specialized Orthopedics, INC. | $112.37 | 2019-2022 | |
| Stryker Corporation | $84.84 | 2025 | Gamma |
| Medinc of Texas | $69.21 | 2024-2025 | |
| Nuvasive, INC. | $37.03 | 2022 | |
| Ge Healthcare | $11.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pablo Castaneda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.